Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,943,046
-
Share change
-
-694,997
-
Total reported value
-
$2,517,000
-
Price per share
-
$0.64
-
Number of holders
-
35
-
Value change
-
-$556,957
-
Number of buys
-
11
-
Number of sells
-
14
Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q2 2017
As of 30 Jun 2017,
OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,943,046 shares.
The largest 10 holders included
VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CANNELL PETER B & CO INC, GEODE CAPITAL MANAGEMENT, LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, GARRISON BRADFORD & ASSOCIATES INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and Virtu KCG Holdings LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.